Cargando…
Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy
Assessment of low-grade glioma treatment response remains as much of a challenge as the treatment itself. Proton magnetic resonance spectroscopy ((1)H-MRS) and imaging were incorporated into a study of patients receiving temozolomide therapy for low-grade glioma in order to evaluate and monitor tumo...
Autores principales: | Murphy, P S, Viviers, L, Abson, C, Rowland, I J, Brada, M, Leach, M O, Dzik-Jurasz, A S K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410174/ https://www.ncbi.nlm.nih.gov/pubmed/14970853 http://dx.doi.org/10.1038/sj.bjc.6601593 |
Ejemplares similares
-
Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy
por: Guillevin, R, et al.
Publicado: (2011) -
Back to the future--radiotherapy in high grade gliomas.
por: Brada, M.
Publicado: (1989) -
The Diagnostic Value of Apparent Diffusion Coefficient and Proton Magnetic Resonance Spectroscopy in the Grading of Pediatric Gliomas
por: Yao, Rong, et al.
Publicado: (2021) -
NICE verdict on Temozolomide: where next?
por: Brada, M
Publicado: (2002) -
Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
por: Osman, Mohammed A
Publicado: (2014)